Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group
- PMID: 1360195
- DOI: 10.1002/ana.410320505
Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group
Abstract
Neurochemical assessments were performed on biopsy samples taken from the right frontal lobe of patients diagnosed with Alzheimer's disease (AD), before the implantation of a ventricular catheter and pump assembly for the infusion of bethanechol chloride as an experimental therapy. The pathologically diagnosed patients with AD (n = 35; mean age, 67 +/- 1.5 yr) were compared with a group of samples from normal age-equivalent autopsied controls (n = 22; mean age, 68 +/- 2 yr) and autopsied AD brains (n = 11; mean age, 73 +/- 2 yr). Samples were assayed for choline acetyltransferase (ChAT), acetylcholinesterase, binding to [3H]quinuclidinyl benzilate as an index of total muscarinic cholinergic binding, and [3H]pirenzepine binding as an index of M1 cholinergic receptor subtype binding. Mean levels of ChAT activity were decreased in the biopsied patients to 36% of age-matched autopsied controls. The loss of ChAT activity correlated significantly with the Mini-Mental State Examination, an index of global cognitive function. Mean ChAT activity in autopsied AD cortex was further decreased compared with controls, indicating continuous decline through the course of the disease. Acetylcholinesterase followed a similar, less dramatic decline. No differences were found in [3H]quinuclidinyl benzilate binding or [3H]pirenzepine binding between biopsied and autopsied controls. Neuritic plaque counts did not correlate with either the Mini-Mental State Examination or ChAT activity in the biopsy specimens.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.Ann Neurol. 1990 May;27(5):457-64. doi: 10.1002/ana.410270502. Ann Neurol. 1990. PMID: 2360787
-
Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.Neurobiol Aging. 2006 Sep;27(9):1216-23. doi: 10.1016/j.neurobiolaging.2005.07.010. Epub 2005 Aug 29. Neurobiol Aging. 2006. PMID: 16129514
-
Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease.Arch Neurol. 2005 Mar;62(3):425-30. doi: 10.1001/archneur.62.3.425. Arch Neurol. 2005. PMID: 15767507
-
Molecular forms of acetylcholinesterases in Alzheimer's disease.Fed Proc. 1986 Dec;45(13):2982-8. Fed Proc. 1986. PMID: 2430839 Review.
-
[Neuropathology of Alzheimer's disease and mild cognitive impairment].Rev Neurol. 2003 Jul 16-31;37(2):155-63. Rev Neurol. 2003. PMID: 12938076 Review. Spanish.
Cited by
-
Targeting the Cation-Chloride Co-Transporter NKCC1 to Re-Establish GABAergic Inhibition and an Appropriate Excitatory/Inhibitory Balance in Selective Neuronal Circuits: A Novel Approach for the Treatment of Alzheimer's Disease.Brain Sci. 2022 Jun 15;12(6):783. doi: 10.3390/brainsci12060783. Brain Sci. 2022. PMID: 35741668 Free PMC article. Review.
-
Flavonoid Derivatives as Potential Cholinesterase Inhibitors in Scopolamine-Induced Amnesic Mice: An In Vitro, In Vivo and Integrated Computational Approach.Brain Sci. 2022 Jun 2;12(6):731. doi: 10.3390/brainsci12060731. Brain Sci. 2022. PMID: 35741617 Free PMC article.
-
In vivo vesicular acetylcholine transporter density in human peripheral organs: an [18F]FEOBV PET/CT study.EJNMMI Res. 2022 Apr 1;12(1):17. doi: 10.1186/s13550-022-00889-9. EJNMMI Res. 2022. PMID: 35362761 Free PMC article.
-
CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment.Front Aging Neurosci. 2021 Aug 26;13:704583. doi: 10.3389/fnagi.2021.704583. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34512307 Free PMC article.
-
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.J Neurochem. 2021 Sep;158(6):1394-1411. doi: 10.1111/jnc.15471. Epub 2021 Aug 6. J Neurochem. 2021. PMID: 34272732 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical